Leica Microsystems will provide worldwide support and service for all Viventis Microscopy products from now on. Credit: Shutterstock/Aris-Tect Group.

Netherlands-based Aiosyn has extended the use of its AI-powered quality control (QC) software for digital pathology by upgrading its algorithms, so it is compatible with more types of slide staining.

The company’s AiosynQC solution now works with immunohistochemistry (IHC) slides, in addition to haematoxylin and eosin (H&E) slides.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The software is able to automatically flags areas in the specimen. By identifying the most common artefacts in histology images, the software ensures that pathologists, technicians and researchers only use high-quality images.

According to Aiosyn, the QC solution streamlines workflows by identifying problematic slides before they reach the pathologist and reducing the need for manual checking.

IHC staining is a backbone technique of pathology laboratories, with it being critical in diagnostic work and clinical research.

Digital pathology is a quickly growing area in healthcare. Hospitals are implementing the technology to allow greater throughput of tissue diagnosis and quicker turnaround times of analysis. Major companies such as Fujifilm and Roche are also entering the growing market.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Aiosyn chief technology officer David Tellez said: “Immunohistochemistry is an integral part of modern pathology practices, and we are excited to offer an AI-powered solution for QC compatible with IHC staining, empowering laboratories to further improve their pathology workflow.”

Separately in its portfolio, Aiosyn has also developed an AI tool to detect mitosis in whole slide images. By using deep learning, Mitosis-Breast can highlight mitotic figures in H&E slides. It is currently undergoing CE-mark certification under the EU in vitro medical device regulation.

Medical Device Network Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Medical Device Network Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving medical devices advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now